Business Description
Amerise Biosciences Ltd
ISIN : INE673C01020
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.99 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 24.4 | |||||
3-Year EPS without NRI Growth Rate | 21.3 | |||||
3-Year FCF Growth Rate | 24.3 | |||||
3-Year Book Growth Rate | 1.8 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 93.16 | |||||
9-Day RSI | 83.67 | |||||
14-Day RSI | 77.24 | |||||
3-1 Month Momentum % | 38.55 | |||||
6-1 Month Momentum % | 94.92 | |||||
12-1 Month Momentum % | 82.54 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.46 | |||||
Quick Ratio | 0.46 | |||||
Cash Ratio | 0.41 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -2.3 | |||||
ROA % | -2.27 | |||||
ROIC % | -2.93 | |||||
3-Year ROIIC % | 24.29 | |||||
ROCE % | -2.28 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.58 | |||||
Price-to-Tangible-Book | 1.74 | |||||
EV-to-EBIT | -74.28 | |||||
EV-to-EBITDA | -74.28 | |||||
EV-to-FCF | -47.1 | |||||
Price-to-Projected-FCF | 1.21 | |||||
Earnings Yield (Greenblatt) % | -1.35 | |||||
FCF Yield % | -1.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Amerise Biosciences Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | |||
EPS (TTM) (₹) | -0.02 | ||
Beta | 0.81 | ||
3-Year Sharpe Ratio | -0.29 | ||
3-Year Sortino Ratio | -0.4 | ||
Volatility % | 35.11 | ||
14-Day RSI | 77.24 | ||
14-Day ATR (₹) | 0.066123 | ||
20-Day SMA (₹) | 1.058 | ||
12-1 Month Momentum % | 82.54 | ||
52-Week Range (₹) | 0.55 - 1.33 | ||
Shares Outstanding (Mil) | 66.07 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Amerise Biosciences Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Amerise Biosciences Ltd Stock Events
Event | Date | Price (₹) | ||
---|---|---|---|---|
No Event Data |
Amerise Biosciences Ltd Frequently Asked Questions
What is Amerise Biosciences Ltd(BOM:531681)'s stock price today?
When is next earnings date of Amerise Biosciences Ltd(BOM:531681)?
Does Amerise Biosciences Ltd(BOM:531681) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |